Dodge & Cox Becton Dickinson & CO Transaction History

Dodge & Cox

$159 Billion
Q2 2024

A detailed history of Dodge & Cox transactions in Becton Dickinson & CO stock. As of the latest transaction made, Dodge & Cox holds 980 shares of BDX stock, worth $236,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares

980

Previous 980 -0.0%

Holding current value

$236,278

Previous $242,000 5.37%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$229.71 - $259.35 $298,623 - $337,155	-1,300 Reduced 57.02%	980 $242,000
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $483,168 - $526,974	-2,100 Reduced 47.95%	2,280 $573,000
Q1 2021 May 14, 2021	SELL	$232.09 - $256.88 $46,418 - $51,376	-200 Reduced 4.37%	4,380 $1.07 Million
Q4 2020 Feb 11, 2021	SELL	$221.92 - $245.94 $17,753 - $19,675	-80 Reduced 1.72%	4,580 $1.15 Million
Q2 2020 Aug 13, 2020	SELL	$219.9 - $263.41 $153,930 - $184,387	-700 Reduced 13.06%	4,660 $1.12 Million
Q3 2019 Nov 13, 2019	SELL	$230.58 - $256.08 $69,174 - $76,824	-300 Reduced 5.3%	5,360 $1.36 Million
Q1 2019 May 14, 2019	SELL	$206.05 - $248.17 $4,121 - $4,963	-20 Reduced 0.35%	5,660 $1.41 Million
Q4 2018 Feb 14, 2019	SELL	$204.73 - $257.93 $71,655 - $90,275	-350 Reduced 5.8%	5,680 $1.28 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $139,842 - $153,600	-600 Reduced 9.05%	6,030 $1.57 Million
Q1 2018 May 14, 2018	SELL	$205.46 - $240.27 $102,730 - $120,135	-500 Reduced 7.01%	6,630 $1.44 Million
Q4 2017 Feb 14, 2018	SELL	$189.0 - $222.64 $113,400 - $133,584	-600 Reduced 7.76%	7,130 $1.53 Million
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $1.44 Million - $1.54 Million	7,730	7,730 $1.52 Million

Others Institutions Holding BDX

# of Institutions

1,734

Shares Held

252M

Call Options Held

586K

Put Options Held

649K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $68.8B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account